CJC-1295 DAC is a synthetic peptide studied for its role in growth hormone–releasing hormone (GHRH) signaling pathways. Designed with a Drug Affinity Complex (DAC), this modified structure allows the peptide to bind to circulating proteins, which may extend its stability and activity in experimental settings. Researchers explore CJC-1295 DAC to better understand how long-acting GHRH analogs influence endocrine signaling and growth hormone regulation.